Ongoing remission after intensive ALL-type chemotherapy in pediatric intestinal T-cell lymphoma.

  • Carsten Friedrich
  • Johanna Schrum
  • Andreas Chott
  • Gritta Janka-Schaub
  • Hartmut Kabisch

Abstract

A rare case of primary intestinal T-cell lymphoma (ITL) of an 8-year-old boy is reported. Medium- to large-sized tumor cells were betaF1+, CD3+, CD8+. TIA-1+, but CD4-, CD5-, CD30-, CD56-, CD20-, CD79a-, TdT-, consistent with an intraepithelial lymphocyte (IEL) origin. They showed monoclonal rearrangement of the T-cell receptor gamma-chain and no evidence of EBV infection. No clinical, histologic, laboratory, or genetic evidence of celiac disease was detected. In adults, ITL is often associated with enteropathy and has a very poor outcome. Our patient remains in first remission 30 months after finishing the acute lymphoblastic leukemia protocol COALL-07-03 high risk standard.

Bibliographical data

Original languageGerman
Article number4
ISSN1545-5009
Publication statusPublished - 2010
pubmed 20049930